LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Atropine Sulfate Injection, USP in an 8 mg per 20 mL presentation. Fresenius Kabi ...
Atropine is a muscarinic antagonist and is indicated for temporary blockage of severe or life threatening muscarinic effects. Atropine Sulfate Injection is now available in an 8mg per 20mL ...
Administering an injectable product with glass particulate matter could potentially result in inflammation of a vein, granuloma, and blockage of blood vessels or life-threatening blood clot events.
MicroDose Therapeutx Announces Successful Completion of Phase 1 Pilot Study with Inhaled Atropine as Antidote to Combat Effects of Nerve Agent Poisoning MONMOUTH JUNCTION, N.J.--(BUSINESS ...
Hospira, Inc., a Pfizer company, is voluntarily recalling the lots listed in the table below of 4.2% Sodium Bicarbonate Injection, USP ABBOJECT® Glass Syringe, 5 mEq/10 mL; 8.4% Sodium Bicarbonate ...
Manufacturing snags at Hospira, a unit of Pfizer, are helping create shortages of a wide range of injectable drugs, some of which have been voluntarily recalled by the company, the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results